Panbio USA

Panbio was a healthcare diagnostics company focused on rapid in vitro diagnostic products, particularly lateral-flow and point-of-care tests for infectious diseases. The business became known for the Panbio branded rapid tests, including HIV self-testing and COVID-19 antigen diagnostics, which are now marketed within Abbott's diagnostics portfolio. Evidence indicates the U.S. legal entity Panbio Inc was acquired and is no longer an active standalone company, with Panbio functioning primarily as a product brand rather than an independent operating biotech company today. For a biotech or diagnostics analyst, Panbio is best understood as a historically independent diagnostics manufacturer whose branded rapid-testing assets now sit under Abbott's global diagnostics and point-of-care business.